Penn spinout awarded $22 million to develop anti-aging drug, advance cancer treatment
The company, co-founded by 2018 Perelman School of Medicine graduate Christopher Natale and Penn Medicine physician and professor of dermatology Todd Ridky, is developing a pill that provides estrogen benefits.






